Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5NQY
|
||||
| Drug Name |
(S)-N-[(R)-1-Formyl-2-(1H-indol-3-yl)-ethyl]-2-(naphthalene-1-sulfonylamino)-3-phenyl-propionamide
|
||||
| Synonyms |
CHEMBL334405
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H27N3O4S
|
||||
| Canonical SMILES |
O=C[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc3ccccc3)NS(=O)(=O)c4cccc5ccccc45
|
||||
| InChI |
InChI=1S/C30H27N3O4S/c34-20-24(18-23-19-31-27-15-7-6-13-25(23)27)32-30(35)28(17-21-9-2-1-3-10-21)33-38(36,37)29-16-8-12-22-11-4-5-14-26(22)29/h1-16,19-20,24,28,31,33H,17-18H2,(H,32,35)/t24-,28+/m1/s1
|
||||
| InChIKey |
JGJXIKNPRCLINN-YWEHKCAJSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.